Contract facts
FederalNo full NAICS 518210 intel page yet. Browse NAICS intelligence
CENTER FOR VETERINARY MEDICINE ADVERSE DRUG EVENT REPORTING SYSTEM ? DATA MANAGEMENT is a federal award for Fda Office Of Acq Grant Svcs held by Ba-Zai Jv, LLC. Estimated value $25M ($25M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2028). Place of performance: SILVER SPRING, MD.
CENTER FOR VETERINARY MEDICINE ADVERSE DRUG EVENT REPORTING SYSTEM ? DATA MANAGEMENT
Recompete timing
PublicCurrent PoP ends Sep 29, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordBa-Zai Jv, LLC — $19.9M obligated across 14 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40123F19019?
75F40123F19019 (CENTER for veterinary medicine adverse DRUG) is a Fda Office Of Acq Grant Svcs award with an estimated value of $25M, currently held by Ba-Zai Jv, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40123F19019?
Fda Office Of Acq Grant Svcs awarded 75F40123F19019 to Ba-Zai Jv, LLC.
Who is the incumbent on 75F40123F19019?
Ba-Zai Jv, LLC is the incumbent with $19.9M across 14 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.
When does Ba-Zai Jv, LLC’s 75F40123F19019 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.